Markus Ewert, © GE Healthcare

Ablynx: Chief of business

Belgian biopharmaceutical company Ablynx named Markus L.E. Ewert Chief Business Officer (CBO). Effective from 20 June 2017, Dr Ewert will lead the Company's business development and corporate strategy activities and become a member of the Executive Committee.

Until recently, Ewert, who holds a PhD in molecular biology from the University of Heidelberg and an MBA from the University of Chicago, headed the Business Development team of General Electric’s healthcare. Prior to that, he worked at Novartis in its Cardiovascular and Metabolism franchise and later moved to the Molecular Diagnostics unit as Head of Strategy, Global BD&L, and M&A. Before joining Novartis, Ewert was CEO of two biotech companies and had been at The Boston Consulting Group serving as an advisor to pharmaceutical and chemical companies.